C4 THERAPEUTICS INC shareholders Q2 2023

C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 99 filers reported holding C4 THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.

C4 THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 760,657$2,091,8071.16%
Soleus Capital Management, L.P. 2,692,020$7,403,0550.82%
TCG Crossover Management, LLC 1,276,574$3,510,5790.58%
Bain Capital Life Sciences Investors, LLC 1,642,210$4,516,0780.46%
Nextech Invest Ltd. 375,857$1,033,6070.35%
Nantahala Capital Management 1,000,000$2,750,0000.27%
WASATCH ADVISORS LP 7,199,491$19,798,6000.12%
XTX Topco Ltd 201,033$552,8410.10%
GSA CAPITAL PARTNERS LLP 312,135$8580.09%
HARBOR CAPITAL ADVISORS, INC. 58,647$161,2790.03%
State of Wyoming 34,494$94,8590.03%
CORNERCAP INVESTMENT COUNSEL INC 48,047$132,1290.02%
Y-Intercept (Hong Kong) Ltd 75,900$208,7250.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 728,941$2,004,5880.01%
CAXTON ASSOCIATES LP 26,721$73,4830.01%
ArrowMark Colorado Holdings LLC 309,755$851,8260.01%
PDT Partners, LLC 21,432$58,9380.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 100,000$275,0000.01%
ALGERT GLOBAL LLC 59,070$1620.01%
PRELUDE CAPITAL MANAGEMENT, LLC 34,000$93,5000.01%
External links

This page lists C4 THERAPEUTICS INC's shareholders in Q2 2023. To view C4 THERAPEUTICS INC's shareholder history, click here.